CS Genetics

Discovery Tools (Healthcare)

CS Genetics is a private discovery tools (healthcare) company. It has raised $16.9 million across 1 recorded round; the latest was a $16.9 million Series A in Sep 2022.

Last price · $/share
—
Implied valuation
—
Total raised
$16.9M
Last round
Later Stage VC (Series A)
Sep 2022

CS Genetics key facts

  • It has raised $16.9M across 1 recorded rounds; the latest was Later Stage VC (Series A) ($16.9M) in Sep 2022.
Private Market View
More of CS Genetics with a free Private Market View account
  • ·Watch CS Genetics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

CS Genetics funding rounds

1 rounds
Sep 2022Later Stage VC (Series A)$16.9M▮

How much has CS Genetics raised?

CS Genetics has raised $16.9 million across 1 recorded round since 2022. The largest was a $16.9 million Series A in Sep 2022.

About CS Genetics

Industry
Discovery Tools (Healthcare)

Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.

Valuation — not yet priced

CS Genetics doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.